| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/06/2013 | US20130143331 Compositions and methods for photocontrolled hybridization and dehybridization of a nucleic acid |
| 06/06/2013 | US20130143315 Sheet-shaped cell culture dissociation system and method |
| 06/06/2013 | US20130143312 Droplet-based cell culture and cell assays using digital microfluidics |
| 06/06/2013 | US20130143308 Systems and methods for fluorescence detection with a movable detection module |
| 06/06/2013 | US20130143281 Chimeric PUFA Polyketide Synthase Systems and Uses Thereof |
| 06/06/2013 | US20130143275 Crude biological derivatives competent for nucleic acid detection |
| 06/06/2013 | US20130143274 Methods for nucleic acid manipulation |
| 06/06/2013 | US20130143273 Methods for nucleic acid manipulation |
| 06/06/2013 | US20130143271 Novel expression-regulating sequences and expression products in the field of filamentous fungi |
| 06/06/2013 | US20130143254 Co-culture device assembly |
| 06/06/2013 | US20130143253 Method for quantitative measurement of gastric acidity using 13c carbonate salt |
| 06/06/2013 | US20130143252 Method for Detection of Inflammation in the Urinary Tract or Urethra |
| 06/06/2013 | US20130143247 Volatile organic compounds for detecting cell dysplasia and genetic alterations associated with lung cancer |
| 06/06/2013 | US20130143246 Hand-held test meter with analytical test strip ejection mechanism |
| 06/06/2013 | US20130143236 Method for determining sensitivity of tumor cells to dasatinib and computer program |
| 06/06/2013 | US20130143233 Fusion protein having luminescence activity |
| 06/06/2013 | US20130143230 Microfluidic-based cell-culturing platform and method |
| 06/06/2013 | US20130143227 Regulation of wnt/beta-catenin signaling |
| 06/06/2013 | US20130143223 Method of determining kidney transplantation tolerance |
| 06/06/2013 | US20130143220 Systems and methods for sampling of amplification products |
| 06/06/2013 | US20130143219 Methods and compositions for high yield, specific amplification |
| 06/06/2013 | US20130143218 Device for amplifying target nucleic acid |
| 06/06/2013 | US20130143217 Kits for comparative transcript analysis and mutant sequence enrichment |
| 06/06/2013 | US20130143216 Real Time Cleavage Assay |
| 06/06/2013 | US20130143215 Methods of Predicting Methotrexate Efficacy and Toxicity |
| 06/06/2013 | US20130143214 Prostate cancer associated circulating nucleic acid biomarkers |
| 06/06/2013 | US20130143213 Detection of genetic abnormalities |
| 06/06/2013 | US20130143212 Method of Determining the Abundance of a Target Nucleotide Sequence of a Gene of Interest |
| 06/06/2013 | US20130143211 Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
| 06/06/2013 | US20130143210 Method for the prognosis of ovarian carcinoma |
| 06/06/2013 | US20130143208 Oligonucleotide Trapping |
| 06/06/2013 | US20130143207 Methods and compositions for identifying biomarkers useful in characterizing biological states |
| 06/06/2013 | US20130143206 Integrated Analytical System and Method |
| 06/06/2013 | US20130143204 Determination of in vivo dna double-strand break localization and application thereof |
| 06/06/2013 | US20130143203 Compositions for use in identification of adventitious viruses |
| 06/06/2013 | US20130143201 Crystallographic structure of TcPRACA and uses therefor |
| 06/06/2013 | US20130143200 Method for automated sperm manipulation and device for holding sperm and oocytes |
| 06/06/2013 | US20130142887 Use of histone acetyltransferase inhibitors as novel anti-cancer therapies |
| 06/06/2013 | US20130142861 Compositions And Method For Detecting And Treating Abnormal Liver Homeostasis And Hepatocarcinogenesis |
| 06/06/2013 | US20130142823 Cmv glycoproteins and recombinant vectors |
| 06/06/2013 | US20130142760 Atherosclerosis inhibition via modulation of monocyte-macrophage phenotype using apo a-i milano gene transfer |
| 06/06/2013 | US20130142728 Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors |
| 06/06/2013 | DE102012004028B3 Test-Apparatur zur Testung der mikrobiellen Aktivität auf Oberflächen Test apparatus for testing of microbial activity on surfaces |
| 06/06/2013 | DE102011120550A1 Detecting adenovirus target nucleic acid, by contacting sample with amplification oligomer to obtain amplicons, providing conditions sufficient to produce amplicons of adenovirus target nucleic acid, and detecting amplicons |
| 06/06/2013 | DE102011119953A1 Individualized skin treatment comprises e.g. applying and removing adhesive tape on skin surface, obtaining adherent biological material, determining expression and/or activity of differentiation marker, and treating with cosmetic products |
| 06/06/2013 | DE102007058340B4 Verfahren zur Diagnose einer genetischen Prädisposition für eine Gefäßerkrankung A method of diagnosing a genetic predisposition to vascular disease |
| 06/06/2013 | DE102005027906B4 Verfahren zur zeitnahen Erkennung und Vorhersage der Zustandsentwicklung von Zellsuspensionen und/oder zur Optimierung und Steuerung von biotechnologischen Prozessen A method for the timely detection and prediction of the state of development of cell suspensions and / or for the optimization and control of biotechnological processes |
| 06/06/2013 | CA2877081A1 Molecular display method |
| 06/06/2013 | CA2857712A1 Materials and methods related to nsaid chemoprevention in colorectal cancer |
| 06/06/2013 | CA2857530A1 Suppression of non-specific amplification with high-homology oligonucleotides |
| 06/06/2013 | CA2857505A1 Methods of treating breast cancer with taxane therapy |
| 06/06/2013 | CA2857295A1 Automated system for producing induced pluripotent stem cells or differentiated cells |
| 06/06/2013 | CA2857274A1 A ctc biomarker assay to combat breast cancer brain metastasis |
| 06/06/2013 | CA2857159A1 Drug containing carrier into cell for forming immune complex |
| 06/06/2013 | CA2857146A1 Liquid reflux high-speed gene amplification device |
| 06/06/2013 | CA2857114A1 Erbb3 mutations in cancer |
| 06/06/2013 | CA2857073A1 Methods and kits for the prognosis of colorectal cancer |
| 06/06/2013 | CA2857016A1 Dna extraction from seeds using osmoticum |
| 06/06/2013 | CA2856663A1 Method for the detection of nucleic acid synthesis and/or amplification |
| 06/06/2013 | CA2854790A1 High throughput single nucleotide polymorphism assay |
| 06/06/2013 | CA2854427A1 Bifunctional oligonucleotide probe for universal real-time multianalyte detection |
| 06/06/2013 | CA2854197A1 Methods for the phenotypic detection of hcv inhibitor resistant subpopulations |
| 06/06/2013 | CA2851328A1 Method for dosing the control capacity of c1inh |
| 06/06/2013 | CA2850904A1 A single nucleotide polymorphism on chromosome 15 that predicts hcv treatment responses |
| 06/05/2013 | EP2600154A1 Method for generating data set for integrated proteomics, integrated proteomics method using data set for integrated proteomics that is generated by the generation method, and method for identifying causative substance using same |
| 06/05/2013 | EP2600150A2 Method for determining sensitivity of tumor cells to dasatinib and computer program |
| 06/05/2013 | EP2600147A2 Method for screening diabetes treating agent |
| 06/05/2013 | EP2600135A1 Method for preparing sugar chains from antibodies |
| 06/05/2013 | EP2600133A1 Method for forming tissue pieces for tissue array, and device for forming tissue pieces for tissue array |
| 06/05/2013 | EP2599879A1 A quantitative PCR-based method to predict the efficiency of target enrichment for next-generation sequencing using repetitive DNA elements (lines/sines) as negative controls |
| 06/05/2013 | EP2599878A1 Detection method of novel ret fusion |
| 06/05/2013 | EP2599877A1 New pcr sequencing method and use thereof in hla genotyping |
| 06/05/2013 | EP2599868A1 NUCLEIC ACID MOLECULE CAPABLE OF BINDING TO c-Met AND USE THEREOF |
| 06/05/2013 | EP2599860A1 Induced malignant stem cells or pre-induction cancer stem cells capable of self-replication outside of an organism, production method for same, and practical application for same |
| 06/05/2013 | EP2598890A2 Mig6 and therapeutic efficacy |
| 06/05/2013 | EP2598886A1 Method for the identification of catechol o-methyltransferase modulators |
| 06/05/2013 | EP2598661A2 Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures |
| 06/05/2013 | EP2598660A2 Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures |
| 06/05/2013 | EP2598659A2 Method for using gene expression to determine prognosis of prostate cancer |
| 06/05/2013 | EP2598658A1 Probes and primers for detection of dengue |
| 06/05/2013 | EP2598657A2 Microrna patterns for the diagnosis, prognosis and treatment of melanoma |
| 06/05/2013 | EP2598656A1 Control nucleic acids for multiple parameters |
| 06/05/2013 | EP2598655A1 Qualitative and quantitative detection of microbial nucleic acids |
| 06/05/2013 | EP2598654A1 Generic sample preparation |
| 06/05/2013 | EP2598653A1 Generic pcr |
| 06/05/2013 | EP2598652A2 Assays for detection of glycosaminoglycans |
| 06/05/2013 | EP2598651A1 Methods and uses relating to the identification of compound associated with bacterial infection |
| 06/05/2013 | EP2598650A2 Diagnosis of bacterial meningitis based on the measure of ros production in a sample of cerebrospinal fluid |
| 06/05/2013 | EP2598649A1 Method, reagent, and apparatus for detecting a chemical chelator |
| 06/05/2013 | EP2598635A1 Corticogenesis of human pluripotent cells |
| 06/05/2013 | EP2598150A2 Compositions for proliferation of cells and related methods |
| 06/05/2013 | CN202968561U Kit for real-time fluorescence quantitive PCR (Polymerase Chain Reaction) detection of NAT2 gene polymorphism |
| 06/05/2013 | CN103140760A Diagnostic for colorectal cancer |
| 06/05/2013 | CN103140590A Method for diagnosing neurodegenerative diseases |
| 06/05/2013 | CN103140589A Mass spectrometric diagnosis of sepsis without blood culture |
| 06/05/2013 | CN103140581A Retrovirus detection |
| 06/05/2013 | CN103134938A Use of aptamers in proteomics |
| 06/05/2013 | CN103134844A Method for screening and evaluating genetic toxicity of industrial wastewater with complex ingredients |
| 06/05/2013 | CN103131800A Primer group for identifying peste des petits ruminant virus wild strain and vaccine strain and application thereof |
| 06/05/2013 | CN103131799A Primer group for detecting plantain lily plant virus and application thereof |